X4 PHARMACEUTICALS, INC.
Profile
Company Names
X4 PHARMACEUTICALS, INC.
Addresses
955 MASSACHUSETTS AVENUE, CAMBRIDGE, MA 02139
955 MASSACHUSETTS AVENUE, 4TH FLOOR, CAMBIDGE, MA 02139
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142
281 SCHOOL STREET, BELMONT, MA 02478
Phone Numbers
617 315 9696
339-203-1076
617-315-9696
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2012
State Incorporated:
DELAWARE
Total Amount Raised:
$73,234,149.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2017-11-01
$34,999,150.00
$34,999,150.00
$0.00
Equity
2
2015-08-14
$37,499,999.00
$37,500,000.00
$1.00
Equity
1
2015-01-16
$735,000.00
$1,200,000.00
$465,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ISAAC
BLECH
DIRECTOR
SOCIALWISE, INC. (FORMERLY KNOWN AS IDEAEDGE, INC)
| CONTRAFECT CORP
| BILLMYPARENTS, INC.
| CERECOR INC.
| MEDGENICS, INC.
| PREMIER ALLIANCE GROUP, INC.
| EDGE THERAPEUTICS, INC.
| SPENDSMART PAYMENTS CO
| CENTREXION CORP
| RESTORGENEX CORP
| ROOT9B TECHNOLOGIES INC.
| WAVEGUIDE CORP
| X4 PHARMACEUTICALS, INC.
| ROOT9B TECHNOLOGIES, INC.
| INSPIREMD, INC.
| CENTREXION THERAPEUTICS CORP
| SAPIENCE THERAPEUTICS, INC.
| ARIDIS PHARMACEUTICALS, INC.
| X-VAX TECHNOLOGY, INC.
| REGENOVATION, INC.
| DIFFUSION PHARMACEUTICALS INC.
| NACUITY PHARMACEUTICALS, INC.
| ELUCIDA ONCOLOGY, INC.
| MARINA BIOTECH, INC.
| ALVEO TECHNOLOGIES INC.
| VEDANTRA PHARMACEUTICALS, INC.
MICHAEL
GILMAN
DIRECTOR
GENE NETWORK SCIENCES, INC.
| STROMEDIX INC
| X4 PHARMACEUTICALS, INC.
| SCHOLAR ROCK LLC
| ARRAKIS THERAPEUTICS, INC.
| OBSIDIAN THERAPEUTICS, INC.
| SCHOLAR ROCK HOLDING CORP
| 2660 INGALLS ST, LLC
| GREEN HILLS REAL ESTATE, LLC
| KILLINGTON VALLEY HOLDINGS, LLC
| KAUS PR REIT, LLC
| 6980 STUART ST, LLC
| KP PRISM REIT, LLC
ALISON
LAWTON
EXECUTIVE OFFICER
ADAM
MOSTAFA
EXECUTIVE OFFICER
PAULA
RAGAN
EXECUTIVE OFFICER, DIRECTOR
ALAN
E.
WALTS
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
